Business
Greenlane Regains Full Compliance with Nasdaq Continued Listing Rules
Appointment of new independent director, Michael Howe, brings significant expertise in commercial strategy, operations and business development BOCA RATON, FL
About this update from Greenlane Holdings, Inc.
[{"type":"text","content":"Appointment of new independent director, Michael Howe, brings significant expertise in commercial strategy, operations and business development BOCA RATON, FL / ACCESSWIRE / January 15, 2025 / Greenlane Holdings, Inc. (\"Greenlane\" or the \"Company\") (NASDAQ:GNLN), one of the premier global sellers of premium cannabis accessories, child-resistant packaging, and specialty vaporization products, today announced it has regained compliance with Nasdaq Listing Rule 5605(c)(2), which requires Nasdaq listed companies to maintain an audit committee consisting of three independent directors. This development follows the appointment on December 31, 2024 of Mr. Michael C. Howe as an independent director of the Company and as a member of the Company's audit committee, effective immediately. With this appointment, Greenlane is now in full compliance with all Nasdaq continued listing requirements and has remedied all previously announced deficiencies.Mr. Howe has a proven track record of leading and building successful consumer focused businesses across different sectors including consumer goods, fast food restaurants, SaaS products, and innovative healthcare companies. Mr. Howe has more than 40 years of consumer and healthcare experience including management positions with Procter & Gamble and PepsiCo, and CEO positions at Arby's, Minute Clinic (acquired by CVS in 2006), and several technology companies.His leadership and expertise in creating innovative consumer focused brands was demonstrated during his tenure at MinuteClinic, a provider of safe, accessible and convenient healthcare services to the consumer. Mr. Howe joined MinuteClinic in June 2005 as the brand struggled to define a clear national expansion strategy. At that time, the company had established 19 clinics in two markets. Within 15 months Mr. Howe added more than 100 clinics in 13 markets and facilitated the sale of the company to CVS in September 2006. He stayed with CVS as CEO of MinuteClinic for two additional years leading the national expansion from the original 19 clinics to more than 530. After leaving CVS in September of 2008, Mr. Howe focused on supporting start up and early-stage companies in their expansion processes, as an angel investor, board member, and executive. His areas of focus include branding, marketing, site development, operational leadership and org...